MedTrace Logo

Assessment in Patients After Thoracic Surgery

NCT03300622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-10-03

No results posted yet for this study

Summary

Lung cancer is the leading cause of death in men and the second in women with a 5 year survival in Europe of less than 15%. One of the methods most used for its treatment is pulmonary resection. The objective of this study is to analyze the clinical profile presented to patients after pulmonary resection.

Conditions

  • Thoracic Surgery

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Marie Carmen Valenza, PT, PhD · Universidad de Granada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-06-30
Completion
2018-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03300622 on ClinicalTrials.gov